Literature DB >> 12746747

Atrial electrophysiology and mechanisms of atrial fibrillation.

Stanley Nattel1.   

Abstract

Atrial fibrillation is the most common cardiac arrhythmia in clinical practice, and its management remains challenging. A solid understanding of the scientific basis for atrial fibrillation therapy requires insight into the mechanisms underlying the arrhythmia, about which an enormous amount has been learned over the past 10 years. The basic information presently available about atrial fibrillation mechanisms is reviewed. The particular properties of normal atrial electrophysiology are discussed, including salient ionic determinants of the atrial action potential and key anatomic features. Reviewed are three crucial arrhythmia mechanisms long held to be involved in atrial fibrillation: 1) rapid ectopic activity, 2) single-circuit reentry with fibrillatory conduction, and 3) multiple-circuit reentry. The determinants of each and the evidence for their involvement in clinical and/or experimental atrial fibrillation are noted. The physiological consequences, various contributing mechanisms, and clinical implications of the role of atrial-tachycardia remodeling are analyzed. Atrial-tachycardia remodeling links the potential mechanisms of atrial fibrillation, since atrial fibrillation beginning by any mechanism is likely to cause tachycardia-remodeling and thus promote the maintenance of atrial fibrillation by multiple-circuit reentry. Atrial structural remodeling is discussed as a paradigm of atrial fibrillation in which the classic features required for reentry (reduced refractory period and reentrant wavelength) may be lacking. Finally, the importance of recent insights into potential genetic determinants of atrial fibrillation is reviewed. The classic understanding of atrial fibrillation pathophysiology saw the different possible mechanisms as being alternative and opposing hypotheses. We now consider the multiple potential mechanisms as contributing to the pathophysiology of the arrhythmia to a different extent in different clinical settings and interacting with each other in a dynamic way at various stages of the natural history in many patients. It is hoped that this improved mechanistic understanding will lead to the development of improved therapeutic options.

Entities:  

Mesh:

Year:  2003        PMID: 12746747     DOI: 10.1177/107424840300800102

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  17 in total

1.  Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.

Authors:  Serge Sicouri; Jonathan Blazek; Luiz Belardinelli; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-03-09

2.  Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy.

Authors:  Carlos Oberti; Lejin Wang; Lin Li; Jiamei Dong; Shaoqi Rao; Wei Du; Qing Wang
Journal:  Circulation       Date:  2004-12-13       Impact factor: 29.690

Review 3.  Monogenic atrial fibrillation as pathophysiological paradigms.

Authors:  Saagar Mahida; Steven A Lubitz; Michiel Rienstra; David J Milan; Patrick T Ellinor
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

Review 4.  Store-Operated Calcium Entry in the Cardiovascular System.

Authors:  Xian Liu; Zui Pan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.

Authors:  Monika Gawałko; Thomas A Agbaedeng; Arnela Saljic; Dominik N Müller; Nicola Wilck; Renate Schnabel; John Penders; Michiel Rienstra; Isabelle van Gelder; Thomas Jespersen; Ulrich Schotten; Harry J G M Crijns; Jonathan M Kalman; Prashanthan Sanders; Stanley Nattel; Dobromir Dobrev; Dominik Linz
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

6.  Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.

Authors:  Iuliia Polina; Hailey J Jansen; Tiesong Li; Motahareh Moghtadaei; Loryn J Bohne; Yingjie Liu; Pooja Krishnaswamy; Emmanuel E Egom; Darrell D Belke; Sara A Rafferty; Martin Ezeani; Anne M Gillis; Robert A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-20       Impact factor: 11.205

Review 7.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 8.  Role of neural modulation in the pathophysiology of atrial fibrillation.

Authors:  Shailesh Male; Benjamin J Scherlag
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

9.  Spontaneous, pro-arrhythmic calcium signals disrupt electrical pacing in mouse pulmonary vein sleeve cells.

Authors:  Katja Rietdorf; Martin D Bootman; Michael J Sanderson
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 10.  Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes.

Authors:  Basil S Karam; Alejandro Chavez-Moreno; Wonjoon Koh; Joseph G Akar; Fadi G Akar
Journal:  Cardiovasc Diabetol       Date:  2017-09-29       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.